Inion secures R&D (research and development) plans with £30m London IPO (initial public offering) - update
This article was originally published in Clinica
Executive Summary
Finnish biodegradable implants developer Inion has succeeded in raising around £33m ($62.3m) before expenses in an initial public offering (IPO) on London's main stock market, the company announced today.